Title:
WT1 CANCER ANTIGEN PEPTIDE AND PEPTIDE CONJUGATE BODY CONTAINING SAME
Document Type and Number:
WIPO Patent Application WO/2018/181648
Kind Code:
A1
Abstract:
The present invention pertains to: a WT1 peptide of 10-12 residues and having a cysteine residue; a peptide conjugate body containing same; and a combination of the WT1 peptide or the peptide conjugate body and a WT1 helper peptide.
Inventors:
BAN HITOSHI (JP)
TAKANASHI YOSUKE (JP)
TAKANASHI YOSUKE (JP)
Application Number:
PCT/JP2018/013092
Publication Date:
October 04, 2018
Filing Date:
March 29, 2018
Export Citation:
Assignee:
SUMITOMO DAINIPPON PHARMA CO LTD (JP)
INT INST CANCER IMMUNOLOGY INC (JP)
INT INST CANCER IMMUNOLOGY INC (JP)
International Classes:
C07K7/06; A61K39/00; A61P35/00; A61P35/02; A61P37/04; C07K7/08; C07K19/00
Domestic Patent References:
| WO2010037395A2 | 2010-04-08 | |||
| WO2014157692A1 | 2014-10-02 | |||
| WO2014157704A1 | 2014-10-02 | |||
| WO2000006602A1 | 2000-02-10 | |||
| WO2002079253A1 | 2002-10-10 | |||
| WO2014157692A1 | 2014-10-02 | |||
| WO2002047474A1 | 2002-06-20 | |||
| WO2006078059A1 | 2006-07-27 | |||
| WO2000006602A1 | 2000-02-10 | |||
| WO2002079253A1 | 2002-10-10 | |||
| WO2003106682A1 | 2003-12-24 | |||
| WO2004026897A1 | 2004-04-01 | |||
| WO2004063903A2 | 2004-07-29 | |||
| WO2007063903A1 | 2007-06-07 | |||
| WO2010123065A1 | 2010-10-28 | |||
| WO2005053618A2 | 2005-06-16 | |||
| WO2007047764A2 | 2007-04-26 | |||
| WO2007120673A2 | 2007-10-25 | |||
| WO2005045027A1 | 2005-05-19 | |||
| WO2010037395A2 | 2010-04-08 | |||
| WO2000018795A2 | 2000-04-06 | |||
| WO2002028414A1 | 2002-04-11 | |||
| WO2003037060A2 | 2003-05-08 | |||
| WO2004100870A2 | 2004-11-25 |
Foreign References:
| JP2017068541A | 2017-04-06 | |||
| US2868691A | 1959-01-13 | |||
| US3095355A | 1963-06-25 |
Other References:
CLINICAL CANCER RESEARCH, vol. 15, no. 17, 2009, pages 5323 - 5337
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF UNITED STATES OF AMERICA, vol. 102, no. 47, 2005, pages 17107 - 17112
THE JOURNAL OF IMMUNOLOGY, vol. 183, 2009, pages 5526 - 5536
THE JOURNAL OF IMMUNOLOGY, vol. 184, 2010, pages 4725 - 4732
J. IMMUNOL., vol. 155, 1994, pages 4307
"1995", IMMUNOGENETICS, vol. 41, pages 178
INT. J. CANCER, vol. 100, 2002, pages 565 - 570
NAT. MED., vol. 4, 1998, pages 321 - 327
CANCER IMMUNOL. IMMUNOTHER., vol. 51, 2002, pages 271
SAMBROOK J.FRISCH E. F.MANIATIS T.: "A Laboratory Manual", 1989, COLD SPRING HARBER LABORATORY PRESS, pages: 6.3.1 - 6.3.6
"Current protocols in Molecular Biology", 1987, JOHN WILEY AND SONS
"Peptide Synthesis", vol. 14, 1991, HIROKAWA SHOTEN, article "Development of Pharmaceutical Product sequential"
"The Proteins", vol. 2, 1976, ACADEMIC PRESS INC.
"peptide synthesis", 1975, MARUZEN CO., LTD.
DM. GLOVER: "Basics and Experiment of peptide synthesis", 1985, MARUZEN CO., LTD.
DEVELOPMENT OF PHARMACEUTICAL PRODUCT SUBSEQUENT, vol. 14
HIROKAWA SHOTEN, PEPTIDE SYNTHESIS, 1991
T. MANIATIS ET AL.: "Molecular Cloning", 1983, CSH LABORATORY
"Protective Groups in Organic Synthesis", 1990, JOHN WILEY & SONS, INC.
TETRAHEDRON LETTERS, vol. 37, no. 9, pages 1347 - 1350
NAT REV DRUG DISCOV., vol. 12, 2013, pages 130 - 146
NIKKEI MEDICAL CANCER REVIEW, vol. 9, 2014
NAT REV IMMUNOL., vol. 14, 2014, pages 559 - 69
CLIN. MICROBIOL. REV., vol. 7, 1994, pages 277 - 289
INT J CANCER., vol. 100, 2002, pages 565 - 70
PLOS ONE, vol. 3, no. 11, November 2008 (2008-11-01), pages e3658
See also references of EP 3604325A4
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF UNITED STATES OF AMERICA, vol. 102, no. 47, 2005, pages 17107 - 17112
THE JOURNAL OF IMMUNOLOGY, vol. 183, 2009, pages 5526 - 5536
THE JOURNAL OF IMMUNOLOGY, vol. 184, 2010, pages 4725 - 4732
J. IMMUNOL., vol. 155, 1994, pages 4307
"1995", IMMUNOGENETICS, vol. 41, pages 178
INT. J. CANCER, vol. 100, 2002, pages 565 - 570
NAT. MED., vol. 4, 1998, pages 321 - 327
CANCER IMMUNOL. IMMUNOTHER., vol. 51, 2002, pages 271
SAMBROOK J.FRISCH E. F.MANIATIS T.: "A Laboratory Manual", 1989, COLD SPRING HARBER LABORATORY PRESS, pages: 6.3.1 - 6.3.6
"Current protocols in Molecular Biology", 1987, JOHN WILEY AND SONS
"Peptide Synthesis", vol. 14, 1991, HIROKAWA SHOTEN, article "Development of Pharmaceutical Product sequential"
"The Proteins", vol. 2, 1976, ACADEMIC PRESS INC.
"peptide synthesis", 1975, MARUZEN CO., LTD.
DM. GLOVER: "Basics and Experiment of peptide synthesis", 1985, MARUZEN CO., LTD.
DEVELOPMENT OF PHARMACEUTICAL PRODUCT SUBSEQUENT, vol. 14
HIROKAWA SHOTEN, PEPTIDE SYNTHESIS, 1991
T. MANIATIS ET AL.: "Molecular Cloning", 1983, CSH LABORATORY
"Protective Groups in Organic Synthesis", 1990, JOHN WILEY & SONS, INC.
TETRAHEDRON LETTERS, vol. 37, no. 9, pages 1347 - 1350
NAT REV DRUG DISCOV., vol. 12, 2013, pages 130 - 146
NIKKEI MEDICAL CANCER REVIEW, vol. 9, 2014
NAT REV IMMUNOL., vol. 14, 2014, pages 559 - 69
CLIN. MICROBIOL. REV., vol. 7, 1994, pages 277 - 289
INT J CANCER., vol. 100, 2002, pages 565 - 70
PLOS ONE, vol. 3, no. 11, November 2008 (2008-11-01), pages e3658
See also references of EP 3604325A4
Attorney, Agent or Firm:
SAMEJIMA, Mutsumi et al. (JP)
Download PDF: